| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/03/2008 | WO2007104573A3 Improved snuff composition |
| 01/03/2008 | WO2007102052A3 Foam containing unique oil globules |
| 01/03/2008 | WO2007084541A3 Central administration of stable formulations of therapeutic agents for cns conditions |
| 01/03/2008 | WO2007081679A3 Medical imaging reference devices |
| 01/03/2008 | WO2007067873A3 Lotion-treated tissue and towel |
| 01/03/2008 | WO2007051520A3 Method and device for producing very fine particles and coating such particles |
| 01/03/2008 | WO2007026261A3 Formulations containing losartan and/or its salts |
| 01/03/2008 | WO2006060759A8 A sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal |
| 01/03/2008 | WO2005123131A3 High pressure spray-dry of bioactive materials |
| 01/03/2008 | WO2005087825A3 Temperature sensitive polymers |
| 01/03/2008 | WO2005007196A3 Lipid encapsulated interfering rna |
| 01/03/2008 | WO2004070995A3 System and method for medical device authentication |
| 01/03/2008 | WO2003087335A3 Preservation of bioactive materials by spray drying |
| 01/03/2008 | WO2001028590A3 PHARMACEUTICAL COMPOSITIONS CONTAINING N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL ESTER |
| 01/03/2008 | US20080004602 Methods and systems for neural maintenance and regeneration |
| 01/03/2008 | US20080004601 Analyte Monitoring and Therapy Management System and Methods Therefor |
| 01/03/2008 | US20080004305 Intranasal Opioid Compositions |
| 01/03/2008 | US20080004218 Methods for enhanced epithelial permeation of y2 receptor-binding peptides for treating and preventing obesity |
| 01/03/2008 | US20080003651 producing cyclotetrasaccharide of glucose units; use as filler, stabilizer, sweetener among other things in drugs, cosmetics and foods |
| 01/03/2008 | US20080003310 Eye drops |
| 01/03/2008 | US20080003298 Emulsifying a reverse micelle solution with with a solution of condensation agent (H2O), catalyst, polar solvent and active material , to generate droplets containing active material; and adding a silica-, alumina-, titanium dioxide-, iron oxide-, and/or zirconium dioxide-based gel precursor solution |
| 01/03/2008 | US20080003297 Taste-masking oral dosage form and method of preparing the same |
| 01/03/2008 | US20080003295 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 01/03/2008 | US20080003294 Methods for pulmonary delivery of interleukin-2 |
| 01/03/2008 | US20080003293 Use of Buckysome or Carbon Nanotube for Drug Delivery |
| 01/03/2008 | US20080003292 Nanoparticles and method for the production thereof |
| 01/03/2008 | US20080003291 Antibiotic and deodorant material and a preparation method thereof |
| 01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/03/2008 | US20080003289 Method for the Production of Effervescent Granules in a Vacuum |
| 01/03/2008 | US20080003288 Responsive microgel and methods related thereto |
| 01/03/2008 | US20080003287 Extended release perforated tablet |
| 01/03/2008 | US20080003286 Sustained delivery alfuzosin compositions |
| 01/03/2008 | US20080003285 Immediate Release Pharmaceutical Tablets With Height Greater Than Width |
| 01/03/2008 | US20080003284 Levothyroxine compositions and methos |
| 01/03/2008 | US20080003283 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 01/03/2008 | US20080003281 Modified Release Tablet Formulations for Proton Pump Inhibitors |
| 01/03/2008 | US20080003280 Combination cough treatment compounds and method of treating common coughs |
| 01/03/2008 | US20080003279 Coenzyme Q10 Formulation and Process Methodology for Soft Gel Capsules Manufacturing |
| 01/03/2008 | US20080003277 Agent for improving tissue penetration |
| 01/03/2008 | US20080003276 Glucocoricoid is an amphipathic weak acid or base such as methylprednisolone sodium hemisuccinate encapsulated in a liposome; treating rheumatoid arthritis or other autoimmune disease, provided they are not neurodegenerative disorders |
| 01/03/2008 | US20080003275 Treatment of Premature Ejaculation |
| 01/03/2008 | US20080003274 Decompressive thermogenic bandage |
| 01/03/2008 | US20080003272 flowable, containing thrombin, Factor XIII, fibrinogen, and a calcium salt; for wound healing in surgery, tissue therapy and/or as supporting material for biological factors; effervescent foams; biodegradable supports, bandages |
| 01/03/2008 | US20080003271 Moisturizing, cosmetic, or anti-wrinkle composition comprising at least two hyaluronic acid fractions or salts thereof, wherein first fraction has molecular weight of 8,000-100,000 Da, and second fraction has molecular weight of 500,000-1,100,000 Da; may also have use in treating osteoarthritis, cancer |
| 01/03/2008 | US20080003269 Poncirus Trifoliata Extract for Preventing and Treating Ischemic Heart Diseases and Pharmaceutical Composition and Health Food Containing the Same |
| 01/03/2008 | US20080003268 Unit serving appetite suppressant compositions with steroidal glycosides |
| 01/03/2008 | US20080003267 Pharmaceutical Composition |
| 01/03/2008 | US20080003260 Use of 5-fluorourcil, delivered by iontophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skin |
| 01/03/2008 | US20080003258 Composition and Method for Treating Rheumatoid Arthritis |
| 01/03/2008 | US20080003257 Composition and Method for Treating Connective Tissue Damage |
| 01/03/2008 | US20080003250 Novel therapy for herpesvirus infection |
| 01/03/2008 | US20080003244 Inflammation and Oxidative Stress Reducing Compostion for Topical or Oral Administration |
| 01/03/2008 | US20080003205 Tympanic Membrane Repair Constructs |
| 01/03/2008 | US20080000473 pH-Based Methods and Devices for Preventing Hemagglutinin Cell Membrane Fusion |
| 01/03/2008 | DE10245212B4 Verwendung säurehaltiger Mittel zur Desensibilisierung von Zähnen Using acidic agent for desensitization of teeth |
| 01/03/2008 | DE102006029500A1 Verwendung einer antimikrobiellen härtenden Alginatmasse zur topischen Behandlung von Wunden und Entzündungen in der Human-, Zahn- und Veterinärmedizin Use of an antimicrobial curing alginate for the topical treatment of wounds and inflammation in human medicine, dentistry and veterinary medicine |
| 01/03/2008 | CA2659206A1 Formulations comprising a vitamin and the use thereof to make fortified feed and personal care formulations |
| 01/03/2008 | CA2657084A1 Pellet formulation comprising colloidal silicon dioxide |
| 01/03/2008 | CA2656604A1 Injectable formulation of antibiotic and solution for intravenous administration thereof |
| 01/03/2008 | CA2656484A1 Analyte monitoring and therapy management system and methods therefor |
| 01/03/2008 | CA2656438A1 Nanostructured lipid carriers containing riluzole and pharmaceutical formulations containing said particles |
| 01/03/2008 | CA2656277A1 Active agent formulations, methods of making, and methods of use |
| 01/03/2008 | CA2656069A1 Pharmaceutical composition comprising tetrahydrolipstatin |
| 01/03/2008 | CA2655958A1 Process for preparing a solid dosage form |
| 01/03/2008 | CA2655729A1 Controlled crystallization of powders |
| 01/03/2008 | CA2655615A1 A pharmaceutical composition for the oral administration of omega polyenoic fatty acids and one or more active principles incompatible therewith, and a process for its preparation |
| 01/03/2008 | CA2655381A1 Compositions of glycopyrronium salt for inhalation |
| 01/03/2008 | CA2654986A1 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 01/03/2008 | CA2654414A1 Granule and preparation method thereof |
| 01/03/2008 | CA2654264A1 Inhalant powder containing phenylalanine |
| 01/03/2008 | CA2653597A1 Antimicrobial hand towel for touchless automatic dispensers |
| 01/03/2008 | CA2653384A1 Methods for the preparation of biologically active compounds in nanoparticulate form |
| 01/03/2008 | CA2653382A1 A stabilised composition comprising ace inhibitors |
| 01/03/2008 | CA2652226A1 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
| 01/03/2008 | CA2614389A1 Extended release solid pharmaceutical composition containing carbidopa and levodopa |
| 01/02/2008 | EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs |
| 01/02/2008 | EP1873196A1 Porous cellulose aggregate and molding composition thereof |
| 01/02/2008 | EP1872799A1 External preparation, method of applying external preparation, iontophoresis device and transdermal patch |
| 01/02/2008 | EP1872798A1 Intestinal absorptive anti-tumor agent |
| 01/02/2008 | EP1872796A1 Transdermal preparation for external use containing nonsteroidal antiinflammatory/analgesic agent |
| 01/02/2008 | EP1872794A1 Nasal vaccine |
| 01/02/2008 | EP1872788A1 External agent for treating wound |
| 01/02/2008 | EP1872785A1 pharmaceutical composition comprising condensed indole compound |
| 01/02/2008 | EP1872784A1 Medicinal preparation for percutaneous absorption |
| 01/02/2008 | EP1872779A1 Stable multiparticulate pharmaceutical composition comprising tri-and tetracyclic antidepressants |
| 01/02/2008 | EP1872778A1 Stable pharmaceutical composition with rabeprazole sodium |
| 01/02/2008 | EP1872777A1 Pharmaceutical composition comprising tetrahydrolipstatin |
| 01/02/2008 | EP1872776A2 Mousse composition |
| 01/02/2008 | EP1872775A1 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
| 01/02/2008 | EP1872774A1 A pharmaceutical composition adapted for oral transmucosal administration comprising sex hormone and its use |
| 01/02/2008 | EP1872390A2 Multi-layer structure having a predetermined layer pattern including an agent |
| 01/02/2008 | EP1871889A1 A process for producing modified reconstituted sendai viral envelope specific for drug and/or gene delivery to liver cells |
| 01/02/2008 | EP1871424A2 Immunoliposome composition for targeting to a her2 cell receptor |
| 01/02/2008 | EP1871423A2 Nanoparticle/active ingredient conjugate |
| 01/02/2008 | EP1871396A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor |
| 01/02/2008 | EP1871387A1 Intravenous formulations of pyridoxal 5'-phosphate and method of preparation |
| 01/02/2008 | EP1871383A2 Device and methods for treating paranasal sinus conditions |
| 01/02/2008 | EP1871372A1 Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain |
| 01/02/2008 | EP1871366A2 Drug delivery systems for treatment of diseases or conditions |
| 01/02/2008 | EP1871363A1 Combined-step process for pharmaceutical compositions |